Dermatitis, Atopic: all 1,443 studies
Page 7 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.
- Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.CompletedNCT07323719Not applicable
- Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.CompletedNCT07301658Not applicable
- A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.CompletedNCT07284173Phase 1
- A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisActive, not recruitingNCT07277660Phase 2
- A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisSuspendedNCT07265479Phase 3
- A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy SubjectsCompletedNCT07264335Phase 1
- A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT07230860Phase 2
- Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT07220577Phase 2
- A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT07217015Phase 2
- Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic DermatitisCompletedNCT07205081Phase 1
- In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis SkinCompletedNCT07194421
- In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic DermatitisCompletedNCT07194408
- A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsCompletedNCT07190430Phase 1
- Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With DupilumabWithdrawnNCT07187089Phase 4
- Study of LW402 in Moderate-to-Severe Atopic DermatitisCompletedNCT07186387Phase 2
- A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic DermatitisCompletedNCT07185282Phase 3
- MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic DermatitisCompletedNCT07182864Phase 1/2
- A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy AdultsCompletedNCT07172321Phase 1
- A Study Evaluating TRIV-509 in Atopic DermatitisActive, not recruitingNCT07167758Phase 2
- Phase 2b Study of EVO756 in Adults With Atopic DermatitisCompletedNCT07150845Phase 2
- Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic DermatitisTerminatedNCT07146971Phase 1
- Social Media Follow-up Nursing for Atopic DermatitisCompletedNCT07142993Not applicable
- Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic DermatitisCompletedNCT07113366Phase 1
- A Study Evaluating BFB759 in Moderate to Severe Atopic DermatitisActive, not recruitingNCT07105488Phase 2
- A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic DermatitisCompletedNCT07103369Phase 1
- A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic DermatitisCompletedNCT07103174Phase 2
- The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic DermatitisCompletedNCT07098000
- A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic DermatitisCompletedNCT07072273Not applicable
- A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic DermatitisCompletedNCT07071610Phase 2
- Clinical Observation of Topical Lidocaine Cream Combined With Moisturizing Cream in the Treatment of Atopic DermatitisCompletedNCT07067541Not applicable
- A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function EnhancementCompletedNCT07066150Not applicable
- The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.CompletedNCT07046039
- The Effects of an Oral Prebiotic and an Oral Synbiotic Supplement in Combination With a Topical Lotion and Soap On EczemaActive, not recruitingNCT07041892Not applicable
- An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT07027527Phase 1
- Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic DermatitisCompletedNCT07017348Not applicable
- Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic DermatitisCompletedNCT07016087Not applicable
- ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT07011706Phase 2
- Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient OutcomesCompletedNCT07009483Not applicable
- A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch BurdenCompletedNCT07006792Phase 4
- Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisCompletedNCT06998056Phase 2
- A Study for HSK44459 in Participants With Atopic DermatitisActive, not recruitingNCT06996912Phase 2
- The Potential Role of Compounds Derived From Ultra-processed Foods in the Pathogenesis of Atopic Dermatitis in Pediatric AgeCompletedNCT06996327
- Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding EmollientsCompletedNCT06983561
- The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male VolunteersCompletedNCT06974292Phase 1
- Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)CompletedNCT06945458Phase 1
- Replication of the Heads Up Atopic Dermatitis Trial With Registry DataTerminatedNCT06937788
- A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis ParticipantsCompletedNCT06934980
- Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic DermatitisCompletedNCT06930365Not applicable
- The Impact of Botox on Neuroimmune Interactions in Atopic DermatitisActive, not recruitingNCT06928246Phase 1
- A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic DermatitisCompletedNCT06923228Phase 2
- Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult ParticipantsActive, not recruitingNCT06920693Phase 1
- Lebrikizumab in Moderate-to-severe Atopic DermatitisActive, not recruitingNCT06906497Phase 4
- Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic DermatitisCompletedNCT06891040Phase 2
- A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)TerminatedNCT06881251Phase 2
- A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT06863961Phase 2
- French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)Active, not recruitingNCT06837454
- A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisActive, not recruitingNCT06832618Phase 3
- The Effects of a Botanical Moisturizer, an Oral Supplement, and an Unscented Soap on Eczema and ItchCompletedNCT06819709Not applicable
- Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic DermatitisCompletedNCT06810050Phase 2
- Effect of Probiotic Bifidobacterium Bifidum PRL 2010 in the Prevention of Atopic Dermatitis in ChildrenCompletedNCT06809465Not applicable
- A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT06790121Phase 2
- Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic PruritusCompletedNCT06787586Phase 1
- Tralokinumab for Dupilumab FailuresTerminatedNCT06773455Phase 4
- Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus PlaceboCompletedNCT06763939
- A Herbal Compound for EczemaActive, not recruitingNCT06758752Phase 2
- Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.CompletedNCT06756438Not applicable
- An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry SkinCompletedNCT06747897
- A Study of Barzolvolimab in Patients With Atopic DermatitisActive, not recruitingNCT06727552Phase 2
- Efficacy Study of EVO301 in Moderate to Severe Atopic DermatitisCompletedNCT06723405Phase 2
- A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic DermatitisActive, not recruitingNCT06718101Phase 2
- Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic DermatitisActive, not recruitingNCT06701331Phase 3
- A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT06700499Phase 2
- A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.CompletedNCT06687512Not applicable
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy AdultsCompletedNCT06686797Phase 1
- An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 SubstratesCompletedNCT06686628Phase 1
- A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.CompletedNCT06673654Phase 1
- Efficacy and Safety of Roflumilast Cream in Subjects With Atopic DermatitisCompletedNCT06631170Phase 3
- A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®CompletedNCT06614907Phase 1
- Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT06585202Phase 2
- TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)CompletedNCT06578351
- Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic DermatitisCompletedNCT06565117Not applicable
- Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisCompletedNCT06554847Phase 3
- Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic DermatitisCompletedNCT06553417Not applicable
- Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.CompletedNCT06553287Phase 1
- Study of CM512 in Healthy Subjects and Patients With Atopic DermatitisCompletedNCT06553209Phase 1
- To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisActive, not recruitingNCT06552520Phase 3
- Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)CompletedNCT06551363
- A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT06526182Phase 3
- Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic DermatitisCompletedNCT06509243Not applicable
- A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart ReviewCompletedNCT06503536
- Study of CM310 in Adolescent Subjects With Atopic DermatisActive, not recruitingNCT06495229Phase 3
- Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic DermatitisCompletedNCT06492902Not applicable
- A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic DermatitisCompletedNCT06477835Phase 3
- Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic DermatitisCompletedNCT06474728Not applicable
- Topical ENS-002 for Atopic Dermatitis in AdultsTerminatedNCT06469385Phase 1
- A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisActive, not recruitingNCT06461897Phase 3
- MYCobiome Analysis in Atopic Dermatitis With Head and Neck InvolvementCompletedNCT06455891
- A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy ParticipantsCompletedNCT06438263Phase 1
- A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic DermatitisCompletedNCT06436183Phase 2
- Effect of EMD Protocol for Urge on Dermatology-specific Quality of LifeCompletedNCT06427122Not applicable